Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New ICD Provides Maximum Energy on First Shock

By HospiMedica International staff writers
Posted on 07 May 2015
A novel implantable cardioverter defibrillator (ICD) delivers 42 Joules of ultra-high energy on the first shock.

The Inventra DX System provides dual-chamber diagnostic capabilities information with just one specialized defibrillator lead, reducing the risk associated with additional hardware for patients, while at the same time providing valuable clinical information to the physician. More...
The system utilizes the Linoxsmart DX lead with floating dipole, which provides sophisticated atrial signal processing capabilities, even helping to detect silent atrial fibrillation (AF). Proprietary SMART Detection algorithm and MorphMatch functions can discriminate atrial tachyarrythmias, helping reduce the risk of inappropriate shocks.

The Inventra DX System, a product of BIOTRONIK (Berlin, Germany), was approved by the US Food and Drug Administration (FDA), together with the Itrevia ICD Series, a less invasive therapy with an algorithm that can identify successful pain-free therapies for each patient, and dynamically re-apply them as needed. The complete Itrevia DX family includes the Itrevia VR-T, the Itrevia DR-T, and the Itrevia HF-T.

“Physician experts in the field of electrophysiology have indicated that meaningful therapeutic innovations available in Itrevia and Inventra ICDs—like high energy options, DX systems, and CLS—make it easier for physicians to tailor therapy and improve the quality of life for their patients,” said Marlou Janssen, president of BIOTRONIK. “This approval is yet another example of BIOTRONIK's ability to offer unique stand-alone technology to support electrophysiologists as they pursue their life-saving, life-changing work for patients.”

“DX systems use single coil leads, and these leads are definitely my preference, because evidence shows lower long-term complication rates,” said James Stone Jr., MD, of Cardiology Associates of North Mississippi (Tupelo, MS, USA). “In rare cases, patients will present with high defibrillation thresholds that require maximum energy. BIOTRONIK's Inventra DX will be a good alternative for these patients.”

ICD’s or pacemakers that pace either the right atrium or the right ventricle are called single-chamber pacemakers. Those that pace both the right atrium and right ventricle of the heart and require two pacing leads are called dual-chamber pacemakers. And those that pace the right atrium and both the right and left ventricles are called biventricular.


Related Links:

BIOTRONIK
Cardiology Associates of North Mississippi


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.